$KONEF: KETAMINE ONE (OTC: KONEF | NEO: MEDI) business model incorporates a growing roster of clinics, telemedicine, contract research and digital therapeutics including novel wearable devices.
As legalization rolls out across North America, the psychedelic-assisted therapy sector is exploding with growth and ketamine clinics have arguably become the most profitable vertical in the space.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.